(Q42598970)

English

Triple nucleoside combination zidovudine/lamivudine/abacavir versus zidovudine/lamivudine/nelfinavir as first-line therapy in HIV-1-infected adults: a randomized trial

scientific article published on April 1, 2003

Statements

Triple nucleoside combination zidovudine/lamivudine/abacavir versus zidovudine/lamivudine/nelfinavir as first-line therapy in HIV-1-infected adults: a randomized trial (English)
Jean-Michel Livrozet
Alain Lafeuillade
Christian Aquilina
Didier Troisvallets
Jean-Philippe Mamet
CNA3007 Study Group

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit